A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
Category: Trade Association
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] …
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...] …
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
A drug industry vendor and a conservative non-profit each urged a full federal appeals court to rehear a case on [...] …
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Sen. John Thune (R-S.D.), who is spearheading a major bipartisan 340B reform package, told hospital executives Tuesday that 340B legislation [...] …
Supporters recently submitted enough signatures to qualify for the ballot a California ballot initiative that aims to codify the governor’s [...] …